H.pylori gastritis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 30: Line 30:
*The acid output reaches pre-infection levels after several weeks but the ascorbic acid remains lower than normal for the duration of chronic gastritis, indicating that it is due to persisting inflammation rather than hypochlorhydria.<ref name="pmid8174949">{{cite journal| author=Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF et al.| title=Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. | journal=Gut | year= 1993 | volume= 34 | issue= 8 | pages= 1038-41 | pmid=8174949 | doi= | pmc=1374349 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8174949  }} </ref>
*The acid output reaches pre-infection levels after several weeks but the ascorbic acid remains lower than normal for the duration of chronic gastritis, indicating that it is due to persisting inflammation rather than hypochlorhydria.<ref name="pmid8174949">{{cite journal| author=Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF et al.| title=Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. | journal=Gut | year= 1993 | volume= 34 | issue= 8 | pages= 1038-41 | pmid=8174949 | doi= | pmc=1374349 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8174949  }} </ref>


<small>Histology</small>
<small>'''Histology'''</small>
*Surface epithelial degeneration
*Surface epithelial degeneration
*Increased cell exfoliation
*Increased cell exfoliation
*Increased neutrophil polymorphonuclear leucocytes in the superficial lamina propria
*Increased neutrophil polymorphonuclear leucocytes in the superficial lamina propria
Updated Sydney classification (Sydney criteria for gastritis)
<small>'''Updated Sydney classification (Sydney criteria for gastritis)'''</small>
{| class="wikitable"
{| class="wikitable"
!Feature
!Feature

Revision as of 20:16, 9 January 2017

Helicobacter pylori infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Gastritis
Peptic ulcer disease
Gastric adenocarcinoma
MALT lymphoma

Causes

Differentiating Helicobacter pylori infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Guideline Recommendation

ACG guidelines
ESPGHAN and NASPGHAN guidelines

History and Symptoms

Physical Examination

Diagnostic tests

Endoscopic tests
Nonendoscopic tests

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

H.pylori gastritis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of H.pylori gastritis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on H.pylori gastritis pathophysiology

CDC on H.pylori gastritis pathophysiology

H.pylori gastritis pathophysiology in the news

Blogs on H.pylori gastritis pathophysiology

Directions to Hospitals Treating Helicobacter pylori infection

Risk calculators and risk factors for H.pylori gastritis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Pathophysiology

The H.pylori induced gastritis includes the following stages: They are

  • The acute phase
  • Active chronic gastritis
  • Atrophy
  • Intestinal metaplasia

The acute phase

  • In majority of patients, the initial acute phase of gastritis is subclinical and is of short duration.
  • The organisms are spontaneously cleared in a small minority of people, especially in childhood.
  • In the majority of cases, the infection is not eliminated and there will be gradual accumulation of chronic inflammatory cells over the next 3 or 4 weeks.[1]

pathogenesis

  • Following transmission, H.pylori penetrates the mucous layer of stomach and multiplies close to the surface epithelial cells.
  • Following adhesion to epithelial cells, the bacteria releases lipopolysaccharides and chemotactic mediators which penetrate the surface epithelial cells.[2]Crabtree, J. E. "Gastric mucosal inflammatory responses to Helicobacter pylori." Alimentary pharmacology & therapeutics 10.Sup1 (1996): 29-37.
  • These bacterial factors attract the polymorphonuclear leukocytes to the site of infection and also caused mast cell degranulation, which releases acute inflammatory mediators. MAst cell degranulation leads to:
  • Increased vascular permeability
  • Increased polymorph emigration
  • Increased expression of leukocyte adhesion molecules
  • The macrophages release IL-1 and tumor necrosis factor alpha (TNF-α) which stimulates gastric epithelium to produce IL-8.
  • The acute phase is associated with profound hypochlorhydria and a decreased ascorbic acid secretion into the gastric juice.[3]
  • The acid output reaches pre-infection levels after several weeks but the ascorbic acid remains lower than normal for the duration of chronic gastritis, indicating that it is due to persisting inflammation rather than hypochlorhydria.[3]

Histology

  • Surface epithelial degeneration
  • Increased cell exfoliation
  • Increased neutrophil polymorphonuclear leucocytes in the superficial lamina propria

Updated Sydney classification (Sydney criteria for gastritis)

Feature Non-atrophic

Helicobacter

Atrophic Helicobacter Autoimmune
Inflammation pattern Antral or diffuse Antrum & corpus, mild inflammation Corpus only
Atrophy & metaplasia Nil Atrophy present, metaplasia at incisura Corpus only

References

  1. Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ; et al. (1991). "Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations". Gut. 32 (11): 1415–8. PMC 1379180. PMID 1752479.
  2. Slomiany BL, Piotrowski J, Slomiany A (1998). "Induction of caspase-3 and nitric oxide synthase-2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide". Biochem Mol Biol Int. 46 (5): 1063–70. PMID 9861460.
  3. 3.0 3.1 Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF; et al. (1993). "Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations". Gut. 34 (8): 1038–41. PMC 1374349. PMID 8174949.